XML 29 R17.htm IDEA: XBRL DOCUMENT
v3.21.2

Stock Options | 12 Months Ended
--- | ---
Jun. 30, 2021
Stock Options [Abstract] |
Stock Options | 11. STOCK OPTIONS In 2012, pursuant to the recommendation of the Board of Directors, the stockholders ratified the creation of the Company’s 2012 Omnibus Incentive Plan (the “2012 Plan”), which superseded the 1990 Flexible Incentive Plan (the "1990 Plan"). The 2012 Plan is administered by a committee of the Board of Directors and provides for granting of various stock-based awards including stock options to eligible participants, primarily officers and certain key employees. A total of 2,000,000 shares of common stock were available under the terms of the 2012 Plan plus shares outstanding under the 1990 Plan that expired or were otherwise forfeited, canceled or terminated after July 25, 2012, the Effective Date of the 2012 Plan. As of June 30, 2021, there were 540,308 options available for future grants. Options vest over a 3 to 5 year period from the date of grant, with a maximum term of 5 to 10 years. The Company's policy is to issue new shares when stock options are exercised. The fair value of each stock option grant was estimated as of the date of grant using the Black-Scholes pricing model. The resulting compensation cost for fixed awards with graded vesting schedules is amortized on a straight-line basis over the vesting period for the entire award. Forfeitures are accounted for as they occur. The expected term of awards granted is determined based on historical experience with similar awards, giving consideration to the expected term and vesting schedules. The expected volatility is determined based on the Company’s historical stock prices over the most recent period commensurate with the expected term of the award. The risk-free interest rate is based on U.S. Treasury zero-coupon issues with a remaining term commensurate with the expected term of the award. As of June 30, 2021, there was $1,223,200 of total unrecognized compensation cost related to stock options granted under the 2012 Plan. This cost is expected to be recognized over a weighted average period of 2.72 years. The Company recognized stock-based compensation expense of $619,137 and $549,594 in 2021 and 2020, respectively. These expenses were included in selling, general and administrative expenses. Options are granted at a price equal to or greater than the market value of the common stock on the date of grant. The per share weighted average fair value of the stock options granted during the years ended June 30, 2021 and 2020 were $1.12 and $1.26, respectively. The fair value of each option granted is estimated on the date of grant using the Black-Scholes option-pricing model. For the options granted in 2021 and 2020, the Company used the following weighted-average assumptions:
|  | 2021 |  |  | 2020
Expected stock price volatility |  | 77% |  |  | 74%
Risk free interest rate |  | 0.34% |  |  | 1.87%
Expected dividend yield |  | —% |  |  | —%
Expected life of options (years) |  | 6.0 |  |  | 6.1
The following table identifies options granted, exercised, canceled, or available for exercise pursuant to the 1990 Plan and the 2012 Plan:
|  |  |  |  |  |  |  |  |  |  |  | Aggregate
|  |  |  |  |  |  |  |  |  | Weighted |  | Intrinsic
|  |  |  |  |  |  | Weighted |  | Average |  | Value of
|  |  |  | Stock |  | Average |  | Remaining |  | In-The-
|  | Number of |  | Options |  | Exercise |  | Contractual |  | Money
|  | Shares |  | Price Range |  | Price |  | Life - Years |  | Options
Shares under option at June 30, 2019 |  | 2,592,875 |  | $ | 1.77 - $6.28 |  | $ | 2.96 |  | 4.23 |  | $ | 48,280
Granted |  | 555,000 |  | $ | 1.97 - $2.17 |  | $ | 2.08 |  |  |  |  |
Exercised |  | — |  |  | — |  |  | — |  |  |  |  |
Expired |  | (362,000) |  | $ | 2.20 - $6.28 |  | $ | 3.53 |  |  |  |  |
Forfeited |  | (64,000) |  | $ | 1.77 - $2.65 |  | $ | 2.15 |  |  |  |  |
Shares under option at June 30, 2020 |  | 2,721,875 |  | $ | 1.77 - $6.00 |  | $ | 2.73 |  | 4.82 |  | $ | —
Granted |  | 615,000 |  | $ | 1.73 - $2.11 |  | $ | 1.84 |  |  |  |  |
Exercised |  | (1,203,875) |  | $ | 1.77 - $6.00 |  | $ | 2.75 |  |  |  |  |
Expired |  | (385,000) |  | $ | 1.77 - $5.24 |  | $ | 3.24 |  |  |  |  |
Forfeited |  | — |  |  | — |  |  | — |  |  |  |  |
Shares under option at June 30, 2021 |  | 1,748,000 |  | $ | 1.73 - $6.00 |  | $ | 2.29 |  | 4.86 |  | $ | 36,594,280
Exercisable as of June 30, 2020 |  | 1,408,709 |  | $ | 1.77 - $6.00 |  | $ | 3.12 |  | 2.61 |  | $ | —
Exercisable as of June 30, 2021 |  | 288,000 |  | $ | 1.73 - $6.00 |  | $ | 3.19 |  | 2.81 |  | $ | 5,767,425
The aggregate intrinsic value of outstanding and exercisable stock options is defined as the difference between the market value of the Company's stock on any given date and the exercise price, multiplied by the number of in-the-money outstanding and exercisable stock options. ‎ A summary of intrinsic value and cash received from stock option exercises and fair value of vested stock options for the fiscal years ended June 30, 2021 and 2020 is as follows:
| 2021 |  | 2020
Total intrinsic value of stock options exercised | $ | 31,877,285 |  | $ | —
Cash received from stock option exercises | $ | 3,306,272 |  | $ | —
Total fair value of stock options vested | $ | 550,093 |  | $ | 483,461
Total recognized tax benefit | $ | 6,545,430 |  | $ | —
|  |  |  |  | Weighted
|  |  |  |  | Average
|  |  |  |  | Grant Date
|  | Shares |  |  | Fair Value
Non-vested as of June 30, 2019 |  | 1,272,584 |  |  | 1.19
Granted |  | 555,000 |  |  | 1.26
Vested |  | (450,418) |  |  | 1.07
Forfeited |  | (64,000) |  |  | 1.39
Non-vested as of June 30, 2020 |  | 1,313,166 |  |  | 1.26
Granted |  | 615,000 |  |  | 1.12
Vested |  | (468,166) |  |  | 1.17
Forfeited |  | - |  |  | 0
Non-vested as of June 30, 2021 |  | 1,460,000 |  |  | 1.23

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration